[ad_1]
Researchers at King’s College London published a new report on the long-standing COVID-19 condition and described the patients who may have it.
The study came from 4,182 users of COVID-19 Symptom Research Software That Tested Positive For coronavirus. According to a Fox News article, those users continued to monitor their health even after their recovery.
The researchers observed that up to 28 days, 558 of these COVID-19 the patients suffered symptoms. These include exhaustion, dyspnoeaand headache.
The analysis further indicates that 189 people suffered from symptoms for more than eight weeks, while the other 95 could already be 12 weeks or more. However, the researchers have noted that these are only optimistic figures.
(Photo: Getty Images)
WUHAN, China – January 22: People wear face masks while waiting in Hankou Train station on January 22, 2020, in Wuhan, China. A new contagious coronavirus known as “2019-nCoV“was discovered in Wuhan last week. Health officials stepped up their efforts to contain the spread of the similar to pneumonia disease that medical experts confirmed can be transmitted from person to person. Cases have been reported in other countries, including the United States. States, Thailand, Japan, Taiwan and South Korea. Wuhan is reported to be suspending all public transportation at 10 a.m. on January 23, 2020.
What is it and how do you handle it?
Long COVID-19 affects patients who have already been cured of coronavirus but they continue to suffer from different symptoms such as persistent exhaustion, shortness of breath or migraines. While they also report that problems return during their recovery, they may still have trouble concentrating and heart problems.
Signs of long-term COVID-19 They were divided into two categories by the researchers. Respiratory problems like shortness of breath, coughing, headaches, and exhaustion fall into the first category. The second was multisystemic, which influences multiple areas of the body, including the heart, brain, and intestines.
In an article from King’s College London, King’s College London Professor of Genetic Epidemiology and COVID-19 Symptom Study Principal Investigator Tim Spector said that although many people suffer from moderate COVID-19, patients will continue to report one in 50 symptoms of coronavirus for more than 12 weeks.
He also said that in addition to thinking about deaths from the virus, treatments for those who suffer long-term COVID-19 it must also be offered. “While we wait for a vaccine, it is vital that we work together to stop the spread of coronavirus through lifestyle changes and more rigorous self insulating with positive symptoms or tests ” Spector additional.
Factors
Age, weight, sex, and respiratory condition are among the variables that cause COVID-19. In fact, 22 percent of long-term COVID-19 patients are over 70 years old, more than twice as many as 18-49 year olds. Those with a higher average body mass index and female patients are also more likely to experience COVID-19, but it can also affect younger men.
Meanwhile, a lot COVID-19 It can also grow among people who have asthma and others who have had different symptoms early in their illness. The researchers, however, did not notice strong links to other health problems.
Rehabilitation and care
While the work has not yet been peer reviewed and launched in medRxiv have a prepress, the researchers say they have been able to build a model that can identify those who are likely to suffer long COVID-19 and help establish an early intervention approach for this syndrome.
“It is important that we use the knowledge we have gained from the first wave of the pandemic to reduce the long-term impact of the second, “said Dr. Claire Steves Who Spectoris co-leader investigator.
Steves He also said the investigation could pave the way for long-term prevention and care of COVID-19 and encouraged the public to download the research and join the initiative and solve the syndrome.
The Public Health Service in the United Kingdom. confirmed that it will offer specialized support to those who suffer long-term COVID-19 syndrome.
READ ALSO: Astrazeneca COVID-19 Vaccine trials will continue even after the death of a volunteer
See more news and information about COVID-19 in Science Times.
[ad_2]
